NPY and obesity due to melanocortin 4 receptor deficiency: In addition, NPY upregulation may influence VPA anticancer treatment of neuroblastomas [1], and counteracting hypothalamic NPY effects may help improve VPA-induced weight gain and obesity without interfering with the desired central effects of VPA [164].